Radiofrequency ablation of a hepatic neoplasm in a patient with an abdominal pacemaker

Cardiology Journal

Volumn 16, Issue 3, 2009, Pages 264-268

  Asensio, Enrique Lafuente ^a,b   López, Telma G ^a   Guerrero, Manuel H ^a   Orea, Arturo T ^a   González, Adrián A ^a   Montejo, Gerardo R ^a   Nájera, Emma O ^a   Castillo, Lilia M ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSIDAD DEL VALLE DE MÉXICO   (Mexico)

Author keywords

Abdomen neoplasia; Interference; Liver; Pacemaker; Radiofrequency ablation

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CASE REPORT; DEVICE INFECTION; ENDOCARDITIS; HEART ATRIUM FIBRILLATION; HEPATITIS C; HUMAN; LIVER CELL DAMAGE; LIVER TUMOR; MALE; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; PROTEIN BLOOD LEVEL; RADIOFREQUENCY; RADIOFREQUENCY ABLATION; SINUS NODE DYSFUNCTION; TRICUSPID VALVE REPAIR; TUMOR VOLUME; CATHETER ABLATION; COMPUTER ASSISTED TOMOGRAPHY; ELECTROCARDIOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HEART PACING; MIDDLE AGED; PRACTICE GUIDELINE; RADIOGRAPHY; SICK SINUS SYNDROME; TREATMENT OUTCOME; VIROLOGY;

CARDIAC PACING, ARTIFICIAL; CATHETER ABLATION; ELECTROCARDIOGRAPHY; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PRACTICE GUIDELINES AS TOPIC; SICK SINUS SYNDROME; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 67650504971     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Roguin A, Schwitter J, Vahlhaus C et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace, 2008; 10: 336-346.
2. The task force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. Guidelines for cardiac pacing and cardiac resynchronization therapy. Eur Heart J, 2007; 28: 2256-2295.
3. Hayes D, Charbonneau W, Lewis B, Asirvatham S, Dupuy D, Lexvold N. Radiofrequency treatment of hepatic neoplasms in patients with permanent pacemakers. Mayo Clin Proc, 2001; 76: 950-952.
4. Kolb C, Luik A, Hessling G, Zrenner B. Magnetic catheter navigation system interference with a dual-chamber pacemaker. Cardiovasc Electrophysiol, 2007; 18: 892-893.
5. Ellenbogen K, Wood M, Stambler B. Acute effects of radiofrequency ablation of atrial arrhythmias on implanted permanent pacing systems. Pacing Clin Electrophysiol, 1996; 19: 1287-1295.
6. Sadoul N, Blankoff I, de Chillou C et al. Effects of radiofrequency catheter ablation on patients with permanent pacemakers. J Interv Card Electrophysiol, 1997; 1: 227-233.
7. Chin M, Rosenqvist M, Lee M, Griffin J, Langberg J. The effect of radiofrequency catheter ablation on permanent pacemakers: An experimental study. Pacing Clin Electrophysiol, 1990; 13: 23-29.
8. Venkataramu N, Krishnamurthy M, Casillas J, Latorre L. Radiofrequency ablation of hepatic lesions: A review. Appl Radiol, 2003; 32: 11-26.
9. Rhim H, Dodd G, Chimapalli K et al. Radiofrequency thermal ablation of abdominal tumors: Lessons learned from complications. Radiographics, 2004; 24: 41-52.
10. Orbach S, Bravo S. Recent data from the literature on the biological and pathologic effects of electromagnetic radiation, radio waves and stray currents. Pathol Biol, 1999; 47: 1085-1093.
11. Speit G, Schutz P, Hoffman H. Genotoxic effects of exposure to radiofrequency electromagnetic fields (RF-EMF) in cultured mammalian cells are not independently reproducible. Mutat Res, 2007; 626: 42-47.
12. Takashima Y, Hirose H, Koyama S, Suzuki Y, Taki M, Miyakoshi J. Effects of continuous and intermittent exposure to RF fields with a wide range of SARs on cell growth, survival and cell cycle distribution. Bioelectromagnetics, 2006; 27: 392-400.
13. Naarala J, Hoyto A, Markkanen A. Cellular effects of electromagnetic fields. Altern Lab Anim, 2004; 32: 355-360.
14. Behari J. Issues in electromagnetic field-biointeractions. India J Biochem Biophys, 1999; 36: 352-360.
15. Guertin D, Faheem O, Ling T et al. Electromagnetic interference (EMI) and arrhythmic events in ICD patients undergoing gastrointestinal procedure. Pacing Clin Electrophysiol, 2007; 30: 734-739.
16. Dawes J, Mahabir R, Hillier K, Cassidy M, de Haas W, Gillis A. Electrosurgery in patients with pacemakers/implanted cardioverter defibrillators. Ann Plast Surg, 2006; 57: 33-36.
17. Trigano J. Interferences and cardiac pacemakers-defibrillators. Results of in vivo experiments and radiofrequencies. Arch Mal Coeur Vaiss, 2003: 96 (Spec. 3): 42-45.
18. Andrivet P. Medical implantable devices and electromagnetic compatibility. Arch Mal Coeur Vaiss, 2003; 96 (Spec. 3): 57-64.
19. Michael F, Dorwarth U, Durchlaub I et al. Application of radiofrequency energy in surgical procedures. Are there interactions with ICDs? Pacing Clin Electrophysiol, 2004; 27: 293-298.
20. Carlson M, Wilkoff B, Maisel W et al. Recommendations from the Heart Rhythm Society task force on device performance policies and guidelines. Heart Rhythm, 2006; 3: 1250-1273.